AOD PhD Scholarship Available

PhD SCHOLARSHIP – ALCOHOL’S HARM TO CHILDREN

Melbourne or Perth

3 years @ National Drug Research Institute (NDRI)

 

This three-year Curtin University/NDRI PhD Scholarship will be linked to NHMRC funded research on alcohol’s harm to children and will be for doctoral research into the prevention or reduction of such harms.

Applications are invited in any of these broad research areas:

  • Alcohol’s harm to others, particularly to children affected by others’ drinking due to intentional and unintentional injury
  • Alcohol’s impact on child abuse and neglect as identified in the child protection system
  • Finding interventions that work: How do alcohol-related policy and treatment initiatives for parents and carers assist their children?

 

Applications are open. Click for full details

 

Methamphetamine Treatment Workshops

Via ADACA Update list:

Sydney 9th and 10th March 2016 – early bird date approaching

Looking for better responses for methamphetamine users? Get practical skills from Australian leaders in methamphetamine treatment

Attend our special training days for health and welfare workers, AOD specialists and service managers and team leaders and walk away with real skills you can apply immediately to your work! Our workshops are skills based, practical sessions run by Australian leaders in methamphetamine treatment and research who have been working with methamphetamine users for more than 25 years: A/Prof Nicole Lee, Linda Jenner, Paula Ross.

Choose from one of three treatment skills workshops plus a special half day workshop for those working with families of people who use methamphetamine.

Methamphetamine treatment workshops: 9th March 9:30am – 4:30pm (full day; 3 streams)

Workshop 1Beyond the tip of the iceberg: Responding to methamphetamine use (health and welfare workers)

Workshop 2: Breaking the ice: Tailoring CBT and MI for methamphetmaine users (AOD specialists)

Workshop 3: On thin ice: Creating a methamphetmaine-responsive service (service managers and team leaders)

Early bird $299 (book by 1st Feb 2016)   |   Standard rate $450 (book by 1st Feb 2016)

Working with families workshop: 10th March 9am – 12.30pm (half day)

Workshop 4: Cracks in the ice: Essential skills for working with families of people who use methamphetamine (anyone working or wanting to work with families)

Early bird $199 (book by 1st Feb 2016)   |   Standard Rate $299 (book by 1st Feb 2016)

Special early-bird combined workshop discount rate $166***

*** Attend one of the ice treatment workshops and receive a special 15% off the Working with Families Workshop rate (combined price $465 instead of $498)

Bookings: www.trybooking.com/Booking/BookingEventSummary.aspx?eid=135067

Further info: www.leejenn.com.au/new-ice-training

Register your interest for workshops planned for Perth and working with families workshops in Melbourne early 2016: training@leejenn.com.au

Your workshop facilitators


ASSOCIATE PROFESSOR NICOLE LEE is a practicing psychologist with 25 years experience in AOD and mental health treatment, research and training. She is one of Australia’s leading experts in methamphetamine treatment. She established the Access Point Stimulant Treatment Centre in Melbourne and developed Australia’s gold standard psychological CBT and MI therapy for methamphetamine use. Nicole is Adjunct Associate Professor at NDRI and National President of the Australian Association for Cognitive and Behaviour Therapy.


LINDA JENNER is a registered nurse with 36 years experience in clinical practice, research and training in AOD and mental health. She was the AOD sectors first CNC for Dual Diagnosis and has produced numerous clinical guidelines on methamphetamine for AOD and frontline workers. She has written numerous guidelines for specialist and frontline workers guiding responses to methamphetamine use.


PAULA ROSS is a practicing psychologist and holds a master’s degree in Counselling Psychology. She has worked in the drug and alcohol field for over 20 years and is highly regarded for her extensive experience in working with families. She has conducted research into AOD clinicians’ experience of working with families, is on the Advisory Committee of Family Drug Help at SHARC, and maintains a private practice working with individuals, couples and families with drug and alcohol and other issues.

2016 National Hepatitis Health Promotion Conference

2016 National Hepatitis Health Promotion Conference,  “Navigating the Future – Opportunities through Engagement”.

We are very pleased to advise that registrations are now open and abstracts are now invited for the conference to be held at Rydges Melbourne 19 – 20 May 2016.

The conference will explore the future health promotion response to viral hepatitis in Australia and look at how the sector workforce can maximise engagement and support people affected by viral hepatitis

 You can access further information at the conference website: http://www.hepatitisaustralia.com/health-promotion-conference-2016/

Abstracts are being sought under a number of sub themes. For further information regarding themes and to submit an abstract, please go to the website and click on the “call for abstracts” button.

Abstracts will be considered by an inter-agency selection committee. Those selected to present are required to register for the conference. Delegates may submit more than one paper, however, no more than two abstract presentations will be allocated to each individual.  We will advise of the outcome by 8thApril.

Registrations close Monday 2 May 2016

Abstracts close Friday 18 March, 2016

Any enquiries please email conference2016@hepatitisaustralia.com.

 

New Hepatitis C Treatments

Press release from the AIVL:

“People Who Use Drugs Welcome Decision to ‘Seize the Day’ on New Hepatitis C Treatments”

The Australian Injecting & Illicit Drug Users League (AIVL) celebrates today’s momentous decision by the Australian Government to fund highly effective new hepatitis C treatment medications through their listing on the PBS. In making this decision the Australian Government has taken advantage of an opportunity rarely offered to governments, that is, to end a major public health epidemic by making these highly effective treatments affordable and accessible to the many thousands of Australians living with hepatitis C.

The recently released report from the Federal Parliamentary Inquiry into Hepatitis C in Australia declared in its introductory sentence that: “Hepatitis C, an infectious disease is the most prevalent blood-borne virus in Australia affecting an estimated 230,000 people.” The vast majority of people living with hepatitis C in Australia are people who inject/have injected illicit drugs.

 “Today we stand together with all Australians living with hepatitis C who have been waiting so long to welcome this news. Many people have been delaying treatment in the hope of an announcement like this that will allow people to be treated regardless of genotype and in a way that is affordable for the individual. The investment of $1 billion dollars by the Australian Government to subsidise life-saving treatments has the potential to transform the hepatitis C treatment landscape in Australia” says Annie Madden, AIVL Executive Officer.

For people living with hepatitis C, Australia is in the midst of a public crisis including a dramatic increase in serious liver disease and deaths (from liver cancer and liver failure) associated with chronic hepatitis C infection.  The number of people with at least moderate liver disease has more than doubled in the last 10 years and current hepatitis C mortality rates are estimated at almost 700 deaths per annum. Diagnosis and treatment costs associated with advanced liver disease and cancer are currently almost $80 million annually and chronic hepatitis C is now the leading indication for liver transplantation in Australia.

With extremely low levels of treatment access and uptake and a growing cohort of people with chronic hepatitis C who have been infected for 20 years or more, serious illness, liver transplantation and deaths associated with hepatitis C were set to rise significantly over the coming decade. This $1 billion dollar investment in hepatitis C treatment by the Australian Government is what was required to address this situation.

 “The new generation of hepatitis C treatments with significantly shorter treatment duration, increased tolerability, reduced medications and increased efficacy will significantly improve treatment for people with chronic hepatitis C infection. For the first time ever, we have targets agreed by all federal and state/territory health ministers for both hepatitis C prevention and treatment in the National Hepatitis C Strategy 2014-2017. Providing people living with hepatitis C with affordable access to these life-saving, new generation treatments give us a real chance at meeting the targets in the National Strategy” declared Ms Madden.

 The new generation hepatitis C treatments clear the virus in over 80-90% of people, can PREVENT CANCER and reduce mortality. We just need to ensure these ground-breaking new treatments are delivered in an appropriate way for those most affected and that we address the significant barriers to hepatitis C treatment associated with stigma, discrimination and the ongoing criminalisation of people who use illicit drugs. Currently less than 2% of people accessing NSP have ever had hepatitis C treatment.

“In addition to providing access hepatitis C treatment in tertiary care settings in hospitals, we need to be providing access to treatment in settings that present less barriers for people who inject drugs (PWID) such as community clinics connected with NSPs and primary health care settings that incorporate PWID peer support workers. Making the most of the new generation treatments will require genuine mobilisation and engagement with the main affected community and this means that peer–based drug user organisations must be central in creating those partnerships and pathways to care for people who inject drugs” concluded Ms Madden.

Jobs: Assistant Manager – Cessnock

Assistant Manager 

An exciting opportunity exists to lead a dynamic team within a larger organisation.

We Help Ourselves (WHOS) – Hunter Valley operates a residential Therapeutic Community for 30 men & women within the Cessnock area.

We are currently looking for a highly motivated, reliable person to coordinate the daily duties of the drug and alcohol facility and assist in managing 10 staff members.

Ideal qualities: 

  • AOD or related field Qualifications
  • 2 yrs Experience working in AOD, mental health or related field
  • Experience coordinating teams
  • Good time management
  • Demonstrated written and verbal communication skills
  • Excellent computer literacy
  • 1st aid certificate
  • NSW drivers licence

Desirable:

  • Experience working within a therapeutic community

Remuneration: Negotiated based on qualifications and experience equivalent to SCHDS Award. Salary packaging applies. Applicants required to undergo a Criminal Record Check.

Please forward your resume to gemmac@whos.com.au

If you require any further information contact Gemma Campton, Manager, on (02) 49917000

Applications close: 16/12/15 looking to carry out interviews on the 18/12/15

Bureau of Crime Statistics and Research Seminars

The Bureau of Crime Statistics and Research (BOCSAR) invites you to hear the findings from our two latest research reports followed by refreshments.  
All are welcome to join us so please circulate this invitation among your networks.

Paper 1.         Do domestic violence offenders receive more lenient sentences than non-domestic violent offenders?
                Dr Neil Donnelly & Dr Suzanne Poynton, BOCSAR

Paper 2.         Does going to prison reduce the risk of further offending: The impact of an offenders first prison episode
                Dr Judy Trevena and Dr Don Weatherburn, BOCSAR

Date:                Friday 4 December 2015

Time:         10:00am to 11:30am

Location:        Room 029
                Building 02 (CB02)
                University of Technology
                Broadway Sydney

Map:                link to pdf map

Cost:                Free

RSVP:        by Monday 30 November
                to bocsar_seminars@agd.nsw.gov.au

Brain Science and Drug Use Seminar

What can brain science tell us about CBT? Some say nothing!

Find out how brain science can improve understanding of drug use and its treatment.

 

A/Prof Nicole Lee is one of Australia’s leaders in drug treatment. She is particularly known for her work in methamphetamine treatment and treatment of co-occurring mental health and drug problems.

She is a translational scientist drawing on broad research to improve treatment outcomes.

Nicole is National President of the AACBT as well as Director of The LeeJenn Group, Associate Professor at the National Centre for Education and Training on Addiction and Adjunct Associate Professor at the National Drug Research Institute.

How Drugs Affect the Brain

Drugs affect the brain – that’s why people use them! But both short term and long term users can experience significant brain changes that affect cognition, mental health symptoms and their ability to engage in treatment.

Some of these changes can last 12-18 months post abstinence and relapse rates are between 50% and 80% as a result.

Nicole uses examples from methamphetamine (‘speed’ and ‘ice’) and other drug use, and gives us the non-neuroscientist version of how drugs affect the brain in the long and short term, how that translates to the way users present in treatment and changes that we need to make to ensure treatment is more effective for this group.

When Wednesday 9 December 2015, (registration from 6:30pm) 7:00 to 8:00pm

Venue Bat and Ball, 495 Cleveland Street, Redefine

To download the flyer, go to: http://www.atoda.org.au/wp-content/uploads/AACBT-Pub-Discussion-Nicole-Lee1.pdf

Multi-lingual resource: what is drug and alcohol treatment?

What is drug and alcohol treatment?

A new resource produced by the Drug and Alcohol Multicultural Education Centre explains different types of drug and alcohol treatment, how to access treatment services, support available for friends/family, plus other commonly asked questions in simple, non-medical language.

The resource can be downloaded from www.damec.org.au

2nd National Complex Needs Conference – Details

The Public Health Association of Australia (PHAA) – in conjunction with the National Complex Needs Alliance (NCNA) – is holding the Second National Complex Needs Conference in Canberra on 17-18 November 2015.  This will be the second Australian conference to showcase successful programs/approaches in addressing complex needs – with the broader purpose of identifying what works and how.  Click here to register online.

Keynote speakers at the conference include:

  • Dr Tom Calma AO, National Coordinator, Tackling Indigenous Smoking; Co-Chair of Reconciliation Australia

TOPIC: Justice Reinvestment – is it the policy solution for Australia’s Indigenous incarceration challenge?

  • Bernadette Mitcherson, Executive Director, ACT Corrective Services

TOPIC: Throughcare programs and initiatives for detainees with complex needs in the ACT

  • Kate Carnell AO, CEO, Chamber of Commerce and Industry

TOPIC: A hand up, not a hand out – how the business community can support disadvantaged Australians to re-enter the labour market

  • Kieran Palmer, Clinical Service Manager, Psychologist, Ted Noffs Foundation

TOPIC: Embracing the potential of youth: Integrated treatment approaches to improving outcomes and supporting greatness

  • Sue Miers AM, Chair, National Organisation for Fetal Alcohol Spectrum Disorders (NOFASD)

TOPIC: Comprehensive responses to the needs of children and families affected by Fetal Alcohol Spectrum Disorders

  • Day 2 of the conference will also feature an Opening Address by Yvette Berry MLA, ACT Minister for Housing, Aboriginal and Torres Strait Islander Affairs, Community Services, Multicultural Affairs, Women and Minister assisting the Chief Minister on Social Inclusion and Equality

TOPIC: ACT Government’s Human Services Blueprint and the related Strengthening Families and Local Services Network initiatives.

Among the other program highlights is the Political and Community Perspectives Panel – confirmed panellists include:

  • Kirsten Livermore, A/g Director, Health, Safety, Environment & Community Policy, Minerals Council of Australia and former Federal Member for Capricornia
  • Senator Deborah O’Neill, Chair, Senate Select Committee on Health
  • Dr John Falzon, Chief Executive Officer, St Vincent de Paul Society National Council of Australia
  • Julie Tongs OAM, Chief Executive Officer, Winnunga Nimmityjah Aboriginal Health Service

The Hypothetical Plenary Session: Great expectations – can we meet complex need effectively? – will be facilitated by Genevieve Jacobs, Presenter of Mornings with Genevieve Jacobs on 666 ABC Canberra.  Panellists will explore options for providing comprehensive assistance to a hypothetical family with complex needs.  Panellists include:

  • Sue Murray, Chief Executive Officer, Suicide Prevention Australia
  • Lyn Morgain, Chief Executive, cohealth
  • Camilla Rowland, Chief Executive Officer, Marymead
  • Professor Valsa Eappen, Cooperative Research Centre for Living with Autism Spectrum Disorders
  • Tamara Stewart-Jones, Director, Multicultural Youth South Australia Inc.
  • Sharon Tuffin, Chief Executive Officer (Interim) Karralika Programs Inc.

Click here to view the full Provisional Program for the conference. 

NDARC PhD Scholarship Applications Open

Applications are now open for the NDARC PhD Scholarship starting in Semester 1, 2016

The National Drug and Alcohol Research Centre (NDARC) is offering at least one PhD scholarship to carry out innovative research on drug or alcohol related issues including, but not limited to, prevention activities or clinical interventions for substance use and disorders, epidemiology, health economics and drug policy research.

Please refer to https://ndarc.med.unsw.edu.au/content/scholarships-ndarc for more details and information on how to apply.

Applications close on Wednesday 18 November.